CS logo
small CS logo
Children's National Medical Center - D.C. Center for Cancer and Blood Disorders

Washington, District of Columbia, United States
Hospital in Washington, D.C.
111 Michigan Ave NW, Washington, DC 20010
303 Beds

About Children's National Medical Center - D.C. Center for Cancer and Blood Disorders


Children's National Hospital is a nationally ranked, freestanding, 323-bed, pediatric acute care children's hospital located in Washington D.C. It is affiliated with the George Washington University School of Medicine and the Howard University College of Medicine.
There are 303 beds in Children's National Medical Center - D.C. Center for Cancer and Blood Disorders.
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Children's National Medical Center - D.C. Center for Cancer and Blood Disorders


During the past decade, Children's National Medical Center - D.C. Center for Cancer and Blood Disorders conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators



Clinical Trials Conditions at Children's National Medical Center - D.C. Center for Cancer and Blood Disorders


According to Clinical.Site data, the most researched conditions in "Children's National Medical Center - D.C. Center for Cancer and Blood Disorders" are "Ependymoma" (1 trials) and "Recurrent or Refractory Pediatric Ependymoma" (1 trials). Many other conditions were trialed in "Children's National Medical Center - D.C. Center for Cancer and Blood Disorders" in a lesser frequency.

Clinical Trials Intervention Types at Children's National Medical Center - D.C. Center for Cancer and Blood Disorders


Most popular intervention types in "Children's National Medical Center - D.C. Center for Cancer and Blood Disorders" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Erlotinib" (1 trials), "erlotinib" (1 trials) and "etoposide" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Children's National Medical Center - D.C. Center for Cancer and Blood Disorders


The vast majority of trials in "Children's National Medical Center - D.C. Center for Cancer and Blood Disorders" are 2 trials for "All" genders.

Clinical Trials Status at Children's National Medical Center - D.C. Center for Cancer and Blood Disorders


Currently, there are NaN active trials in "Children's National Medical Center - D.C. Center for Cancer and Blood Disorders". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Children's National Medical Center - D.C. Center for Cancer and Blood Disorders, undefined suspended trials, and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Children's National Medical Center - D.C. Center for Cancer and Blood Disorders, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".